Cannabist Company Holdings Inc
NEO:CBST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (1.7), the stock would be worth CA$0.06 (70% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1 | CA$0.04 |
0%
|
| 3-Year Average | 1.7 | CA$0.06 |
+70%
|
| 5-Year Average | 1.7 | CA$0.06 |
+72%
|
| Industry Average | 2.7 | CA$0.1 |
+178%
|
| Country Average | 1.5 | CA$0.05 |
+52%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| US |
C
|
Cannabist Company Holdings Inc
NEO:CBST
|
227.8m CAD | 1 | -0.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883B USD | 9.4 | 44.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.5B USD | 3.4 | 26 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 2.9 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.6B GBP | 3.7 | 27.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.1B CHF | 2.9 | 20.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
270.2B USD | 2.6 | 15.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 56 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 2.7 | 12.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.8B USD | 1 | 19.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2 | 16.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.9 |
| Median | 1.5 |
| 70th Percentile | 2.9 |
| Max | 566 432.7 |
Other Multiples
Cannabist Company Holdings Inc
Glance View
Cannabist Company Holdings Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Chelmsford, Massachusetts and currently employs 2,505 full-time employees. The company went IPO on 2019-04-29. The Cannabist Company Holdings Inc., formerly Columbia Care Inc., is a cultivator, manufacturer and provider of cannabis products and related services, with licenses in 16 United States jurisdictions. The firm operates approximately 125 facilities, including 94 dispensaries and 31 cultivation and manufacturing facilities, including those under development. The firm is a multi-state provider of cannabis in the United States and delivers products and services to both the medical and adult-use markets. The company has launched Cannabist, its retail brand, creating a national dispensary network that leverages proprietary technology platforms. The firm offers products spanning flower, edibles, oils and tablets, and manufactures various brands, including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber.
